Registration open for Wyss Institute’s 8th annual international symposium
The 8th Annual Wyss International Symposium will focus on innovations in Therapeutic Organ Engineering, with the goal of sharing recent advances in 3D Organ Engineering, Materials Fabrication, and Vascular Integration that are leading to new approaches for therapeutic organ replacement and regenerative medicine. Join us to meet and learn from leading researchers who will share promising new directions and practical insights that are synergistically moving the field forward.
Topics to be covered include:
- Engineered Human Tissue Microenvironments
- 3D Bioprinting of Complex Organ Systems
- Vascular Integration of Organ-Specific Architectures
- Regenerative Biomaterials Design
- …and more!
A list of speakers and the full agenda may be viewed here: https://events.wyss.harvard.edu/agenda
Time and venue:
Friday, Sep 22, 2017, 8:15am – 6:45pm
Joseph B. Martin Conference Center
Harvard Medical School, Boston, MA
How to register:
Registration is free, but required. Visit this page to register now: https://events.wyss.harvard.edu/home Members of the press/media: please select "Journalism & Media" as your Industry on the registration form in order to receive press information.
The Wyss Institute for Biologically Inspired Engineering at Harvard University uses Nature's design principles to develop bioinspired materials and devices that will transform medicine and create a more sustainable world. Wyss researchers are developing innovative new engineering solutions for healthcare, energy, architecture, robotics, and manufacturing that are translated into commercial products and therapies through collaborations with clinical investigators, corporate alliances, and formation of new startups. The Wyss Institute creates transformative technological breakthroughs by engaging in high risk research, and crosses disciplinary and institutional barriers, working as an alliance that includes Harvard's Schools of Medicine, Engineering, Arts & Sciences and Design, and in partnership with Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, Massachusetts General Hospital, the University of Massachusetts Medical School, Spaulding Rehabilitation Hospital, Boston University, Tufts University, Charité – Universitätsmedizin Berlin, University of Zurich and Massachusetts Institute of Technology.